Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody

Human progesterone receptor (PR) is phosphorylated on multiple serine residues (at least seven sites) in a manner that involves distinct groups of sites coordinately regulated by hormone and different kinases. Progress on defining a functional role for PR phosphorylation has been hampered both by th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular endocrinology (Baltimore, Md.) Md.), 2000-01, Vol.14 (1), p.52-65
Hauptverfasser: Clemm, D L, Sherman, L, Boonyaratanakornkit, V, Schrader, W T, Weigel, N L, Edwards, D P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 65
container_issue 1
container_start_page 52
container_title Molecular endocrinology (Baltimore, Md.)
container_volume 14
creator Clemm, D L
Sherman, L
Boonyaratanakornkit, V
Schrader, W T
Weigel, N L
Edwards, D P
description Human progesterone receptor (PR) is phosphorylated on multiple serine residues (at least seven sites) in a manner that involves distinct groups of sites coordinately regulated by hormone and different kinases. Progress on defining a functional role for PR phosphorylation has been hampered both by the complexity of phosphorylation and the lack of simple, nonradioactive methods to detect the influence of ligands and other signaling pathways on specific PR phosphorylation sites in vivo. Toward this end, we have produced monoclonal antibodies (MAbs) that recognize specific phosphorylation sites within human PR including a basal site at Ser 190 (MAb P190) and a hormone-induced site at Ser 294 (MAb P294). Biochemical experiments showed the differential reactivity of the P190 and P294 MAbs for phosphorylated and unphosphorylated forms of PR. Both MAbs recognize specific phosphorylated forms of PR under different experimental conditions including denatured PR protein by Western blots and PR in its native conformation in solution or complexed to specific target DNA. As detected by Western blot of T47D cells treated with hormone for different times, hormone-dependent down-regulation of total PR and the Ser 190 phosphorylation site occurred in parallel, whereas the Ser 294 phosphorylation site was down-regulated more rapidly. This difference in kinetics suggests that the Ser 294 site is more labile than basal sites and is acted upon by distinct phosphatases. A strong preferential hormone-dependent phosphorylation of Ser 294 was observed on PR-B as compared with the amino-terminal truncated A form of PR. This was unexpected because Ser 294 and flanking sequences are identical on both proteins, suggesting that a distinct conformation of the N-terminal domain of PR-A inhibits phosphorylation of this site. That Ser 294 lies within an inhibitory domain that mediates the unique repressive functions of PR-A raises the possibility that differential phosphorylation of Ser 294 is involved in the distinct functional properties of PR-A and PR-B.
doi_str_mv 10.1210/me.14.1.52
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70823135</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70823135</sourcerecordid><originalsourceid>FETCH-LOGICAL-c211t-85990573312984954636ffea5229d121369b8b67efa4f62d43c4dce6bb1165ff3</originalsourceid><addsrcrecordid>eNqFUMtOwzAQ9AFES-HCByCfuCX4ETvOsZSnVIkLnCMnXlOjJA52ipTv4IexRHvmsFppNDuzMwhdUZJTRsltDzktcpoLdoKWRCmVKUWqBTqP8ZMQWghFz9CCEslUWZRL9HPvrIUAw-R0h3c-9H6AzMAIg0kgHnc-pglzpyfnB-wtHoP_gDhBSEwcoIVx8gGvsR4MvsM2ScQEf4PuwOBmxvooEiG4dBLdBFkcoXXWtTj5-bbzQ3LX6YnGm_kCnVrdRbg87BV6f3x42zxn29enl816m7WM0ilToqqIKDmnrFJFJQrJZcqiBWOVSWVwWTWqkSVYXVjJTMHbwrQgm4ZSKazlK3Tzp5sSfe1TpLp3sYWu0wP4faxLohinXPxLpKWghHGZiNcH4r7pwdRjcL0Oc33sm_8C9XWCaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17510236</pqid></control><display><type>article</type><title>Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Clemm, D L ; Sherman, L ; Boonyaratanakornkit, V ; Schrader, W T ; Weigel, N L ; Edwards, D P</creator><creatorcontrib>Clemm, D L ; Sherman, L ; Boonyaratanakornkit, V ; Schrader, W T ; Weigel, N L ; Edwards, D P</creatorcontrib><description>Human progesterone receptor (PR) is phosphorylated on multiple serine residues (at least seven sites) in a manner that involves distinct groups of sites coordinately regulated by hormone and different kinases. Progress on defining a functional role for PR phosphorylation has been hampered both by the complexity of phosphorylation and the lack of simple, nonradioactive methods to detect the influence of ligands and other signaling pathways on specific PR phosphorylation sites in vivo. Toward this end, we have produced monoclonal antibodies (MAbs) that recognize specific phosphorylation sites within human PR including a basal site at Ser 190 (MAb P190) and a hormone-induced site at Ser 294 (MAb P294). Biochemical experiments showed the differential reactivity of the P190 and P294 MAbs for phosphorylated and unphosphorylated forms of PR. Both MAbs recognize specific phosphorylated forms of PR under different experimental conditions including denatured PR protein by Western blots and PR in its native conformation in solution or complexed to specific target DNA. As detected by Western blot of T47D cells treated with hormone for different times, hormone-dependent down-regulation of total PR and the Ser 190 phosphorylation site occurred in parallel, whereas the Ser 294 phosphorylation site was down-regulated more rapidly. This difference in kinetics suggests that the Ser 294 site is more labile than basal sites and is acted upon by distinct phosphatases. A strong preferential hormone-dependent phosphorylation of Ser 294 was observed on PR-B as compared with the amino-terminal truncated A form of PR. This was unexpected because Ser 294 and flanking sequences are identical on both proteins, suggesting that a distinct conformation of the N-terminal domain of PR-A inhibits phosphorylation of this site. That Ser 294 lies within an inhibitory domain that mediates the unique repressive functions of PR-A raises the possibility that differential phosphorylation of Ser 294 is involved in the distinct functional properties of PR-A and PR-B.</description><identifier>ISSN: 0888-8809</identifier><identifier>DOI: 10.1210/me.14.1.52</identifier><identifier>PMID: 10628747</identifier><language>eng</language><publisher>United States</publisher><subject>Amino Acid Sequence ; Animals ; Antibodies, Monoclonal - biosynthesis ; Antibodies, Monoclonal - immunology ; Antibodies, Monoclonal - metabolism ; COS Cells ; Humans ; Kinetics ; Mice ; Mice, Inbred BALB C ; Molecular Sequence Data ; Phosphorylation ; Phosphoserine - metabolism ; Precipitin Tests ; Progesterone - antagonists &amp; inhibitors ; Progesterone Congeners - pharmacology ; Promegestone - pharmacology ; Protein Binding ; Protein Conformation ; Receptors, Progesterone - chemistry ; Receptors, Progesterone - immunology ; Receptors, Progesterone - metabolism ; Serine - metabolism ; Tumor Cells, Cultured</subject><ispartof>Molecular endocrinology (Baltimore, Md.), 2000-01, Vol.14 (1), p.52-65</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c211t-85990573312984954636ffea5229d121369b8b67efa4f62d43c4dce6bb1165ff3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10628747$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Clemm, D L</creatorcontrib><creatorcontrib>Sherman, L</creatorcontrib><creatorcontrib>Boonyaratanakornkit, V</creatorcontrib><creatorcontrib>Schrader, W T</creatorcontrib><creatorcontrib>Weigel, N L</creatorcontrib><creatorcontrib>Edwards, D P</creatorcontrib><title>Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody</title><title>Molecular endocrinology (Baltimore, Md.)</title><addtitle>Mol Endocrinol</addtitle><description>Human progesterone receptor (PR) is phosphorylated on multiple serine residues (at least seven sites) in a manner that involves distinct groups of sites coordinately regulated by hormone and different kinases. Progress on defining a functional role for PR phosphorylation has been hampered both by the complexity of phosphorylation and the lack of simple, nonradioactive methods to detect the influence of ligands and other signaling pathways on specific PR phosphorylation sites in vivo. Toward this end, we have produced monoclonal antibodies (MAbs) that recognize specific phosphorylation sites within human PR including a basal site at Ser 190 (MAb P190) and a hormone-induced site at Ser 294 (MAb P294). Biochemical experiments showed the differential reactivity of the P190 and P294 MAbs for phosphorylated and unphosphorylated forms of PR. Both MAbs recognize specific phosphorylated forms of PR under different experimental conditions including denatured PR protein by Western blots and PR in its native conformation in solution or complexed to specific target DNA. As detected by Western blot of T47D cells treated with hormone for different times, hormone-dependent down-regulation of total PR and the Ser 190 phosphorylation site occurred in parallel, whereas the Ser 294 phosphorylation site was down-regulated more rapidly. This difference in kinetics suggests that the Ser 294 site is more labile than basal sites and is acted upon by distinct phosphatases. A strong preferential hormone-dependent phosphorylation of Ser 294 was observed on PR-B as compared with the amino-terminal truncated A form of PR. This was unexpected because Ser 294 and flanking sequences are identical on both proteins, suggesting that a distinct conformation of the N-terminal domain of PR-A inhibits phosphorylation of this site. That Ser 294 lies within an inhibitory domain that mediates the unique repressive functions of PR-A raises the possibility that differential phosphorylation of Ser 294 is involved in the distinct functional properties of PR-A and PR-B.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibodies, Monoclonal - biosynthesis</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Antibodies, Monoclonal - metabolism</subject><subject>COS Cells</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Molecular Sequence Data</subject><subject>Phosphorylation</subject><subject>Phosphoserine - metabolism</subject><subject>Precipitin Tests</subject><subject>Progesterone - antagonists &amp; inhibitors</subject><subject>Progesterone Congeners - pharmacology</subject><subject>Promegestone - pharmacology</subject><subject>Protein Binding</subject><subject>Protein Conformation</subject><subject>Receptors, Progesterone - chemistry</subject><subject>Receptors, Progesterone - immunology</subject><subject>Receptors, Progesterone - metabolism</subject><subject>Serine - metabolism</subject><subject>Tumor Cells, Cultured</subject><issn>0888-8809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUMtOwzAQ9AFES-HCByCfuCX4ETvOsZSnVIkLnCMnXlOjJA52ipTv4IexRHvmsFppNDuzMwhdUZJTRsltDzktcpoLdoKWRCmVKUWqBTqP8ZMQWghFz9CCEslUWZRL9HPvrIUAw-R0h3c-9H6AzMAIg0kgHnc-pglzpyfnB-wtHoP_gDhBSEwcoIVx8gGvsR4MvsM2ScQEf4PuwOBmxvooEiG4dBLdBFkcoXXWtTj5-bbzQ3LX6YnGm_kCnVrdRbg87BV6f3x42zxn29enl816m7WM0ilToqqIKDmnrFJFJQrJZcqiBWOVSWVwWTWqkSVYXVjJTMHbwrQgm4ZSKazlK3Tzp5sSfe1TpLp3sYWu0wP4faxLohinXPxLpKWghHGZiNcH4r7pwdRjcL0Oc33sm_8C9XWCaA</recordid><startdate>200001</startdate><enddate>200001</enddate><creator>Clemm, D L</creator><creator>Sherman, L</creator><creator>Boonyaratanakornkit, V</creator><creator>Schrader, W T</creator><creator>Weigel, N L</creator><creator>Edwards, D P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TM</scope><scope>7X8</scope></search><sort><creationdate>200001</creationdate><title>Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody</title><author>Clemm, D L ; Sherman, L ; Boonyaratanakornkit, V ; Schrader, W T ; Weigel, N L ; Edwards, D P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c211t-85990573312984954636ffea5229d121369b8b67efa4f62d43c4dce6bb1165ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibodies, Monoclonal - biosynthesis</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Antibodies, Monoclonal - metabolism</topic><topic>COS Cells</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Molecular Sequence Data</topic><topic>Phosphorylation</topic><topic>Phosphoserine - metabolism</topic><topic>Precipitin Tests</topic><topic>Progesterone - antagonists &amp; inhibitors</topic><topic>Progesterone Congeners - pharmacology</topic><topic>Promegestone - pharmacology</topic><topic>Protein Binding</topic><topic>Protein Conformation</topic><topic>Receptors, Progesterone - chemistry</topic><topic>Receptors, Progesterone - immunology</topic><topic>Receptors, Progesterone - metabolism</topic><topic>Serine - metabolism</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Clemm, D L</creatorcontrib><creatorcontrib>Sherman, L</creatorcontrib><creatorcontrib>Boonyaratanakornkit, V</creatorcontrib><creatorcontrib>Schrader, W T</creatorcontrib><creatorcontrib>Weigel, N L</creatorcontrib><creatorcontrib>Edwards, D P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular endocrinology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Clemm, D L</au><au>Sherman, L</au><au>Boonyaratanakornkit, V</au><au>Schrader, W T</au><au>Weigel, N L</au><au>Edwards, D P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody</atitle><jtitle>Molecular endocrinology (Baltimore, Md.)</jtitle><addtitle>Mol Endocrinol</addtitle><date>2000-01</date><risdate>2000</risdate><volume>14</volume><issue>1</issue><spage>52</spage><epage>65</epage><pages>52-65</pages><issn>0888-8809</issn><abstract>Human progesterone receptor (PR) is phosphorylated on multiple serine residues (at least seven sites) in a manner that involves distinct groups of sites coordinately regulated by hormone and different kinases. Progress on defining a functional role for PR phosphorylation has been hampered both by the complexity of phosphorylation and the lack of simple, nonradioactive methods to detect the influence of ligands and other signaling pathways on specific PR phosphorylation sites in vivo. Toward this end, we have produced monoclonal antibodies (MAbs) that recognize specific phosphorylation sites within human PR including a basal site at Ser 190 (MAb P190) and a hormone-induced site at Ser 294 (MAb P294). Biochemical experiments showed the differential reactivity of the P190 and P294 MAbs for phosphorylated and unphosphorylated forms of PR. Both MAbs recognize specific phosphorylated forms of PR under different experimental conditions including denatured PR protein by Western blots and PR in its native conformation in solution or complexed to specific target DNA. As detected by Western blot of T47D cells treated with hormone for different times, hormone-dependent down-regulation of total PR and the Ser 190 phosphorylation site occurred in parallel, whereas the Ser 294 phosphorylation site was down-regulated more rapidly. This difference in kinetics suggests that the Ser 294 site is more labile than basal sites and is acted upon by distinct phosphatases. A strong preferential hormone-dependent phosphorylation of Ser 294 was observed on PR-B as compared with the amino-terminal truncated A form of PR. This was unexpected because Ser 294 and flanking sequences are identical on both proteins, suggesting that a distinct conformation of the N-terminal domain of PR-A inhibits phosphorylation of this site. That Ser 294 lies within an inhibitory domain that mediates the unique repressive functions of PR-A raises the possibility that differential phosphorylation of Ser 294 is involved in the distinct functional properties of PR-A and PR-B.</abstract><cop>United States</cop><pmid>10628747</pmid><doi>10.1210/me.14.1.52</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0888-8809
ispartof Molecular endocrinology (Baltimore, Md.), 2000-01, Vol.14 (1), p.52-65
issn 0888-8809
language eng
recordid cdi_proquest_miscellaneous_70823135
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Amino Acid Sequence
Animals
Antibodies, Monoclonal - biosynthesis
Antibodies, Monoclonal - immunology
Antibodies, Monoclonal - metabolism
COS Cells
Humans
Kinetics
Mice
Mice, Inbred BALB C
Molecular Sequence Data
Phosphorylation
Phosphoserine - metabolism
Precipitin Tests
Progesterone - antagonists & inhibitors
Progesterone Congeners - pharmacology
Promegestone - pharmacology
Protein Binding
Protein Conformation
Receptors, Progesterone - chemistry
Receptors, Progesterone - immunology
Receptors, Progesterone - metabolism
Serine - metabolism
Tumor Cells, Cultured
title Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T07%3A53%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20hormone-dependent%20phosphorylation%20of%20progesterone%20receptor%20A%20and%20B%20forms%20revealed%20by%20a%20phosphoserine%20site-specific%20monoclonal%20antibody&rft.jtitle=Molecular%20endocrinology%20(Baltimore,%20Md.)&rft.au=Clemm,%20D%20L&rft.date=2000-01&rft.volume=14&rft.issue=1&rft.spage=52&rft.epage=65&rft.pages=52-65&rft.issn=0888-8809&rft_id=info:doi/10.1210/me.14.1.52&rft_dat=%3Cproquest_pubme%3E70823135%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17510236&rft_id=info:pmid/10628747&rfr_iscdi=true